![]() You’ll need a good knowledge of the law - particularly medical regulations - but if it’s a fast-paced environment that you’re looking for with the chance to work on the latest pharmaceutical developments, this will be an extremely rewarding career path. This could take the form of clinical trial study reports, marketing applications or regulatory documents regarding the release of the drug. ![]() Working in this domain, you’ll be writing documents that are part of the development process for medical drugs or devices. Here are three avenues you can take: Regulatory Medical Writing There are several career paths you can pursue as a Medical Writer the trick is finding the one that suits you best. But what do you need to know about starting off and finding your first job? Decide what to aim for So there’s never been a better time for you to make that career change and become a medical writer. The UK pharmaceutical market is now worth £21 billion and is projected to continue expanding at a very strong rate. The sector is incredibly diverse, demand for skilled writers is high, and the pay is generous for those who want to get involved in marketing, coding or law, there are spaces for you. Responsible for working closely with doctors, scientists, and other people in the medical and pharmaceutical profession, a medical writer curates a vast array of content that can cover patient information sheets, medical reports, clinical study reports and even regulatory submissions. Then a career as a medical writer might be right for you. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.Do you have a way with words? Do you enjoy expressing yourself through writing- and do you also have a deep-seated interest in the medical industry? ![]() The company assumes no duty to update the information to reflect subsequent developments. The information contained in this website was current as of the date presented. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (No Duty to Update The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Risks and uncertainties include, but are not limited to, general industry conditions and competition general economic factors, including interest rate and currency exchange rate fluctuations the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally global trends toward healthcare cost containment technological advances, new products and patents attained by competitors challenges inherent in new product development, including obtaining regulatory approval the company’s ability to accurately predict future market conditions manufacturing difficulties or delays financial instability of international economies and sovereign risk dependence on the effectiveness of the company’s patents and other protections for innovative products and the exposure to litigation, including patent litigation, and/or regulatory actions. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |